C R Wolf1. 1. Imperial Cancer Research Fund Molecular Pharmacology Unit, Biomedical Research Centre, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom. rooney@icrf.icnet.uk
Authors: J S Wang; X Shen; X He; Y R Zhu; B C Zhang; J B Wang; G S Qian; S Y Kuang; A Zarba; P A Egner; L P Jacobson; A Muñoz; K J Helzlsouer; J D Groopman; T W Kensler Journal: J Natl Cancer Inst Date: 1999-02-17 Impact factor: 13.506
Authors: K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima Journal: Biochem Biophys Res Commun Date: 1997-07-18 Impact factor: 3.575
Authors: Sandi L Navarro; Sabrina Peterson; Chu Chen; Karen W Makar; Yvonne Schwarz; Irena B King; Shuying S Li; Lin Li; Mark Kestin; Johanna W Lampe Journal: Cancer Prev Res (Phila) Date: 2009-03-31
Authors: Michael McMahon; Kathryn H Campbell; A Kenneth MacLeod; Lesley A McLaughlin; Colin J Henderson; C Roland Wolf Journal: PLoS One Date: 2014-11-26 Impact factor: 3.240